
Ampco-Pittsburgh Corporation Issues Reminder Regarding Warrant Expiration
The NYSE has notified the Corporation that trading in the warrants on the NYSE American will be suspended prior to the opening of trading on July 31, 2025 to ensure all trades in the warrants settle in time to allow the purchasers of such warrants to exercise the warrants on or before the Expiration Date.
Further information regarding the warrants is available on the Corporation's website at www.ampcopgh.com under the heading, Investors.
This news release is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
About Ampco-Pittsburgh Corporation
Ampco-Pittsburgh Corporation manufactures and sells highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. Through its operating subsidiary, Union Electric Steel Corporation, it is a leading producer of forged and cast rolls for the global steel and aluminum industries. It also manufactures open-die forged products that are sold principally to customers in the steel distribution market, oil and gas industry, and the aluminum and plastic extrusion industries. The Corporation is also a producer of air and liquid processing equipment, primarily custom-engineered finned tube heat exchange coils, large custom air handling systems and centrifugal pumps. It operates manufacturing facilities in the United States, England, Sweden, and Slovenia and participates in three operating joint ventures located in China. It has sales offices in North America, Asia, Europe, and the Middle East. Corporate headquarters is located in Carnegie, Pennsylvania.
FORWARD-LOOKING STATEMENTS
The Private Securities Litigation Reform Act of 1995 (the 'Act') provides a safe harbor for forward-looking statements made by us or on behalf of Ampco-Pittsburgh Corporation and its subsidiaries (collectively, 'we,' 'us,' 'our,' or the 'Corporation'). This press release may include, but is not limited to, statements about operating performance, trends and events we expect or anticipate will occur in the future, statements about sales and production levels, timing of orders for our products, restructurings, the impact from pandemics and geopolitical conflicts, profitability and anticipated expenses, inflation, the global supply chain, tariffs and global trade, future proceeds from the exercise of outstanding warrants, and cash outflows. All statements in this document other than statements of historical fact are statements that are, or could be, deemed 'forward-looking statements' within the meaning of the Act and words such as 'may,' 'will,' 'intend,' 'believe,' 'expect,' 'anticipate,' 'estimate, 'project,' 'target,' 'goal,' 'forecast' and other terms of similar meaning that indicate future events and trends are also generally intended to identify forward-looking statements. Forward-looking statements speak only as of the date on which such statements are made, are not guarantees of future performance or expectations, and involve risks and uncertainties. For us, these risks and uncertainties include, but are not limited to: inability to maintain adequate liquidity to meet our operating cash flow requirements, repay maturing debt and meet other financial obligations; economic downturns, cyclical demand for our products and insufficient demand for our products; excess global capacity in the steel industry; inability to successfully restructure our operations and/or invest in operations that will yield the best long-term value to our shareholders; liability of our subsidiaries for claims alleging personal injury from exposure to asbestos-containing components historically used in certain products of our subsidiaries; inability to obtain necessary capital or financing on satisfactory terms to acquire capital expenditures that may be necessary to support our growth strategy; inoperability of certain equipment on which we rely; increases in commodity prices or insufficient hedging against increases in commodity prices, reductions in electricity and natural gas supply or shortages of key production materials for us or our customers; inability to satisfy the continued listing requirements of the New York Stock Exchange or the NYSE American Exchange; potential attacks on information technology infrastructure and other cyber-based business disruptions; fluctuations in the value of the U.S. dollar relative to other currencies; changes in the existing regulatory environment; consequences of pandemics and geopolitical conflicts; work stoppage or another industrial action on the part of any of our unions; failure to maintain an effective system of internal control; changes in the global economic environment, inflation, elevated interest rates, recessions or prolonged periods of slow economic growth, and global instability and actual and threatened geopolitical conflict; and those discussed more fully elsewhere in Item 1A, Risk Factors, in Part I of the Corporation's latest Annual Report on Form 10-K and Part II of the latest Quarterly Report on Form 10-Q. We cannot guarantee any future results, levels of activity, performance or achievements. In addition, there may be events in the future that we are not able to predict accurately or control which may cause actual results to differ materially from expectations expressed or implied by forward-looking statements. Except as required by applicable law, we assume no obligation, and disclaim any obligation, to update forward-looking statements whether as a result of new information, events or otherwise.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
6 minutes ago
- Business Wire
General American Investors Files Certified Shareholder Report for Period Ended June 30, 2025
NEW YORK--(BUSINESS WIRE)--General American Investors Company, Inc., a closed-end investment company listed on the New York Stock Exchange (GAM), filed with the U.S. Securities and Exchange Commission (SEC) its Certified Shareholder Report (Form N-CSR) for the six-month period ended June 30, 2025. The Form N-CSR contains the Company's June 30, 2025 Semi-Annual Report and is available at the SEC's website: and the Company's website: The Semi-Annual Report is expected to be mailed to stockholders shortly. The Semi-Annual Report indicates that as of or for the six months ended: * After a distribution of $4.07 per share from net long-term capital gains and a dividend of $0.43 per share paid in December 2024 and a distribution of $0.25 per share from long-term capital gains paid in March 2025. Expand The largest stock holdings in the Company's portfolio as of June 30, 2025, included: Microsoft, Republic Services, Berkshire Hathaway, TJX Companies, and Amazon.
Yahoo
9 minutes ago
- Yahoo
Norwegian Cruise Line shares surge after record second quarter revenue
-- Norwegian Cruise Line Holdings Ltd. reported record second-quarter revenue of $2.52 billion, up 6% YoY, though slightly below analyst expectations of $2.56 billion. The company posted adjusted earnings per share of $0.51, narrowly missing the consensus estimate of $0.52, but demonstrating strong consumer demand across its brands. Norwegian's shares surged 9.6% following the announcement as investors responded positively to the company's strong performance and reaffirmed full-year guidance. The cruise operator reported that bookings have rebounded across all three of its brands, with booking levels now exceeding historical patterns in recent months. The company delivered adjusted EBITDA of $694 million, exceeding its guidance of $670 million. Net yield increased approximately 2.7% on an as-reported basis and 3.1% in constant currency, outperforming guidance of approximately 2.5%. Gross margin per capacity day increased 11% compared to the same period in 2024. "We delivered another record quarter, demonstrating once again the strong customer demand environment, the power of our brands, our outstanding onboard product, and the dedication of our team," said Harry Sommer, president and CEO of Norwegian Cruise Line (NYSE:NCLH) Holdings. Norwegian maintained its full-year 2025 guidance, projecting adjusted EPS of $2.05, representing a 16% increase from 2024. The company expects full-year net yield to increase approximately 2.5% on a constant currency basis versus 2024. The cruise operator also announced expansion plans for its private island destination, Great Stirrup Cay in the Bahamas, including a nearly six-acre waterpark expected to open in summer 2026. Additionally, the company took delivery of Oceania Allura and confirmed orders for two additional next-generation ships. Related articles Norwegian Cruise Line shares surge after record second quarter revenue Apollo economist warns: AI bubble now bigger than 1990s tech mania If Powell goes, does Fed trust go with him? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
Here's Why Inspire Medical Systems (INSP) Retreated in Q2
Baron Funds, an investment management company, released its 'Baron Discovery Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund was up 14.76% (Institutional Shares), outperforming the 11.97% return for the Russell 2000 Growth Index. The fund was up 7.68% year-to-date, well ahead of the Index's -0.48% return. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Baron Discovery Fund highlighted stocks such as Inspire Medical Systems, Inc. (NYSE:INSP). Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The one-month return of Inspire Medical Systems, Inc. (NYSE:INSP) was 2.12%, and its shares lost 9.58% of their value over the last 52 weeks. On July 30, 2025, Inspire Medical Systems, Inc. (NYSE:INSP) stock closed at $131.21 per share, with a market capitalization of $3.87 billion. Baron Discovery Fund stated the following regarding Inspire Medical Systems, Inc. (NYSE:INSP) in its second quarter 2025 investor letter: "Inspire Medical Systems, Inc. (NYSE:INSP) is a medical device company offering a treatment option called hypoglossal nerve stimulation for patients with moderate-to-severe obstructive sleep apnea. Shares declined during the second quarter. The company is in the early stages of commercializing its fifth-generation device, Inspire 5, which reduces procedure time and simplifies the process for surgeons. Management noted that some patients delayed surgery in anticipation of the new device, leading to a slowdown in procedures during the quarter. Shares were also pressured by concerns about new competitors entering the market and the potential long-term impact of GLP-1 weight loss drugs on business, given the link between obesity and sleep apnea. Despite these headwinds, we believe Inspire remains well positioned to grow at a healthy rate, supported by its market leadership and the substantial size of the addressable patient population. We believe the current valuation presents a compelling entry point given the company's long-term growth potential." A medical professional performing a minimally invasive procedure while using the company's technology. Inspire Medical Systems, Inc. (NYSE:INSP) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 37 hedge fund portfolios held Inspire Medical Systems, Inc. (NYSE:INSP) at the end of the first quarter, which was 32 in the previous quarter. Inspire Medical Systems, Inc. (NYSE:INSP) generated revenue of $201.3 million in the first quarter of 2025, representing a 23% increase compared to the first quarter of 2024. While we acknowledge the potential of Inspire Medical Systems, Inc. (NYSE:INSP) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Inspire Medical Systems, Inc. (NYSE:INSP) and shared the list of best medical technology stocks to buy according to analysts. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey.